Expanding coverage of weight-loss drugs like blockbusters from Eli Lilly & Co. and Novo Nordisk A/S would make 12.5 million ...

Novo Nordisk's weight loss drug Wegovy will be available in France from Tuesday. The drug will require a prescription and ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

Shares of WeightWatchers (WW) are climbing after the company announced a compounded GLP-1 medication starting at $129 as it ...

Novo Nordisk's weight loss drug Wegovy will be available in France from Tuesday. The drug will require a prescription and ...

WeightWatchers said it will sell compounded versions of semaglutide — the key ingredient in Novo Nordisk's Ozempic and Wegovy ...

WeightWatchers said on Tuesday it would offer a compounded version of Novo Nordisk's popular obesity drug Wegovy as part of ...

Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat weight-loss drugs to its members.

A rally in the world’s largest technology companies drove stocks higher, with the market rebounding from its worst session in a month. A rout in Treasuries paused as traders waded through remarks from ...

Pfizer Inc.'s stock gained Monday after a report that activist investor Starboard Value has invested $1 billion in the drug company. Bondholders seem to like the news too. Spreads on the company's ...

The compounding pharmacies that supply knockoff Wegovy can only legally make it as long as it remains on the Food and Drug ...

With an estimated 2 million people in the United States taking copycat vers | A compounding industry group has sued the FDA, ...